nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextroamphetamine—SLC6A3—malignant glioma	0.824	1	CbGaD
Dextroamphetamine—SLC18A2—telencephalic ventricle—malignant glioma	0.00929	0.168	CbGeAlD
Dextroamphetamine—SLC6A3—telencephalic ventricle—malignant glioma	0.00703	0.127	CbGeAlD
Dextroamphetamine—TAAR1—central nervous system—malignant glioma	0.00373	0.0674	CbGeAlD
Dextroamphetamine—Tooth disorder—Temozolomide—malignant glioma	0.00265	0.045	CcSEcCtD
Dextroamphetamine—Digestion impaired—Temozolomide—malignant glioma	0.00257	0.0437	CcSEcCtD
Dextroamphetamine—SLC18A2—brainstem—malignant glioma	0.00251	0.0454	CbGeAlD
Dextroamphetamine—SLC18A2—telencephalon—malignant glioma	0.00223	0.0403	CbGeAlD
Dextroamphetamine—Speech disorder—Carmustine—malignant glioma	0.00206	0.0351	CcSEcCtD
Dextroamphetamine—Accidental injury—Carmustine—malignant glioma	0.00201	0.0341	CcSEcCtD
Dextroamphetamine—Speech disorder—Temozolomide—malignant glioma	0.00199	0.0339	CcSEcCtD
Dextroamphetamine—SLC6A3—brainstem—malignant glioma	0.0019	0.0343	CbGeAlD
Dextroamphetamine—Viral infection—Temozolomide—malignant glioma	0.0019	0.0323	CcSEcCtD
Dextroamphetamine—SLC18A2—medulla oblongata—malignant glioma	0.00175	0.0316	CbGeAlD
Dextroamphetamine—SLC6A3—telencephalon—malignant glioma	0.00169	0.0305	CbGeAlD
Dextroamphetamine—SLC18A2—midbrain—malignant glioma	0.0016	0.0289	CbGeAlD
Dextroamphetamine—SLC6A2—brainstem—malignant glioma	0.00153	0.0277	CbGeAlD
Dextroamphetamine—ADRA1A—brainstem—malignant glioma	0.00143	0.0257	CbGeAlD
Dextroamphetamine—Injury—Carmustine—malignant glioma	0.0014	0.0238	CcSEcCtD
Dextroamphetamine—SLC6A2—telencephalon—malignant glioma	0.00136	0.0246	CbGeAlD
Dextroamphetamine—ADRA1B—central nervous system—malignant glioma	0.00128	0.0231	CbGeAlD
Dextroamphetamine—SLC18A2—central nervous system—malignant glioma	0.00127	0.0229	CbGeAlD
Dextroamphetamine—ADRA1A—telencephalon—malignant glioma	0.00127	0.0228	CbGeAlD
Dextroamphetamine—SLC18A2—cerebellum—malignant glioma	0.00124	0.0224	CbGeAlD
Dextroamphetamine—Affect lability—Temozolomide—malignant glioma	0.00123	0.0209	CcSEcCtD
Dextroamphetamine—SLC6A3—midbrain—malignant glioma	0.00121	0.0219	CbGeAlD
Dextroamphetamine—SLC6A3—spinal cord—malignant glioma	0.00118	0.0213	CbGeAlD
Dextroamphetamine—Mood swings—Temozolomide—malignant glioma	0.00118	0.0201	CcSEcCtD
Dextroamphetamine—Pseudoephedrine—IL2—malignant glioma	0.00115	0.127	CrCbGaD
Dextroamphetamine—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00112	0.0191	CcSEcCtD
Dextroamphetamine—SLC6A2—medulla oblongata—malignant glioma	0.00107	0.0193	CbGeAlD
Dextroamphetamine—Benzphetamine—POR—malignant glioma	0.00103	0.113	CrCbGaD
Dextroamphetamine—ADRA1B—brain—malignant glioma	0.00102	0.0184	CbGeAlD
Dextroamphetamine—SLC18A2—brain—malignant glioma	0.00101	0.0182	CbGeAlD
Dextroamphetamine—Erectile dysfunction—Temozolomide—malignant glioma	0.000991	0.0169	CcSEcCtD
Dextroamphetamine—Depression—Carmustine—malignant glioma	0.00099	0.0168	CcSEcCtD
Dextroamphetamine—Photosensitivity reaction—Temozolomide—malignant glioma	0.000982	0.0167	CcSEcCtD
Dextroamphetamine—Weight decreased—Temozolomide—malignant glioma	0.000974	0.0166	CcSEcCtD
Dextroamphetamine—Urinary tract infection—Carmustine—malignant glioma	0.000965	0.0164	CcSEcCtD
Dextroamphetamine—SLC6A3—central nervous system—malignant glioma	0.000959	0.0173	CbGeAlD
Dextroamphetamine—Depression—Temozolomide—malignant glioma	0.000957	0.0163	CcSEcCtD
Dextroamphetamine—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000951	0.0162	CcSEcCtD
Dextroamphetamine—SLC6A3—cerebellum—malignant glioma	0.000937	0.0169	CbGeAlD
Dextroamphetamine—Urinary tract infection—Temozolomide—malignant glioma	0.000933	0.0159	CcSEcCtD
Dextroamphetamine—Diethylpropion—SLC6A3—malignant glioma	0.000933	0.103	CrCbGaD
Dextroamphetamine—CYP2D6—brainstem—malignant glioma	0.00084	0.0152	CbGeAlD
Dextroamphetamine—Erythema multiforme—Temozolomide—malignant glioma	0.000815	0.0139	CcSEcCtD
Dextroamphetamine—SLC6A2—central nervous system—malignant glioma	0.000774	0.014	CbGeAlD
Dextroamphetamine—SLC6A3—brain—malignant glioma	0.000761	0.0137	CbGeAlD
Dextroamphetamine—CYP2D6—telencephalon—malignant glioma	0.000745	0.0135	CbGeAlD
Dextroamphetamine—Tremor—Carmustine—malignant glioma	0.000727	0.0124	CcSEcCtD
Dextroamphetamine—ADRA1A—central nervous system—malignant glioma	0.000719	0.013	CbGeAlD
Dextroamphetamine—Agitation—Carmustine—malignant glioma	0.000713	0.0121	CcSEcCtD
Dextroamphetamine—Lisdexamfetamine—SLC6A3—malignant glioma	0.000707	0.0779	CrCbGaD
Dextroamphetamine—ADRA1A—cerebellum—malignant glioma	0.000703	0.0127	CbGeAlD
Dextroamphetamine—Tremor—Temozolomide—malignant glioma	0.000703	0.012	CcSEcCtD
Dextroamphetamine—Agitation—Temozolomide—malignant glioma	0.000689	0.0117	CcSEcCtD
Dextroamphetamine—Angioedema—Temozolomide—malignant glioma	0.000685	0.0117	CcSEcCtD
Dextroamphetamine—Convulsion—Carmustine—malignant glioma	0.000672	0.0114	CcSEcCtD
Dextroamphetamine—Hypertension—Carmustine—malignant glioma	0.00067	0.0114	CcSEcCtD
Dextroamphetamine—Palpitations—Temozolomide—malignant glioma	0.000663	0.0113	CcSEcCtD
Dextroamphetamine—Chest pain—Carmustine—malignant glioma	0.000661	0.0112	CcSEcCtD
Dextroamphetamine—Anxiety—Carmustine—malignant glioma	0.000658	0.0112	CcSEcCtD
Dextroamphetamine—Convulsion—Temozolomide—malignant glioma	0.00065	0.0111	CcSEcCtD
Dextroamphetamine—Hypertension—Temozolomide—malignant glioma	0.000647	0.011	CcSEcCtD
Dextroamphetamine—Anxiety—Temozolomide—malignant glioma	0.000636	0.0108	CcSEcCtD
Dextroamphetamine—Infection—Carmustine—malignant glioma	0.000629	0.0107	CcSEcCtD
Dextroamphetamine—Dry mouth—Temozolomide—malignant glioma	0.000624	0.0106	CcSEcCtD
Dextroamphetamine—Tachycardia—Carmustine—malignant glioma	0.000618	0.0105	CcSEcCtD
Dextroamphetamine—SLC6A2—brain—malignant glioma	0.000614	0.0111	CbGeAlD
Dextroamphetamine—Anaphylactic shock—Temozolomide—malignant glioma	0.000612	0.0104	CcSEcCtD
Dextroamphetamine—Infection—Temozolomide—malignant glioma	0.000608	0.0103	CcSEcCtD
Dextroamphetamine—Anorexia—Carmustine—malignant glioma	0.000604	0.0103	CcSEcCtD
Dextroamphetamine—Hyperhidrosis—Temozolomide—malignant glioma	0.000592	0.0101	CcSEcCtD
Dextroamphetamine—Anorexia—Temozolomide—malignant glioma	0.000583	0.00992	CcSEcCtD
Dextroamphetamine—Insomnia—Carmustine—malignant glioma	0.000573	0.00974	CcSEcCtD
Dextroamphetamine—ADRA1A—brain—malignant glioma	0.000571	0.0103	CbGeAlD
Dextroamphetamine—Dyspnoea—Carmustine—malignant glioma	0.000565	0.0096	CcSEcCtD
Dextroamphetamine—Somnolence—Carmustine—malignant glioma	0.000563	0.00958	CcSEcCtD
Dextroamphetamine—Insomnia—Temozolomide—malignant glioma	0.000554	0.00942	CcSEcCtD
Dextroamphetamine—Decreased appetite—Carmustine—malignant glioma	0.000551	0.00937	CcSEcCtD
Dextroamphetamine—Gastrointestinal disorder—Carmustine—malignant glioma	0.000547	0.0093	CcSEcCtD
Dextroamphetamine—Dyspnoea—Temozolomide—malignant glioma	0.000546	0.00928	CcSEcCtD
Dextroamphetamine—Somnolence—Temozolomide—malignant glioma	0.000544	0.00926	CcSEcCtD
Dextroamphetamine—Constipation—Carmustine—malignant glioma	0.000542	0.00921	CcSEcCtD
Dextroamphetamine—Dyspepsia—Temozolomide—malignant glioma	0.000539	0.00916	CcSEcCtD
Dextroamphetamine—Decreased appetite—Temozolomide—malignant glioma	0.000532	0.00905	CcSEcCtD
Dextroamphetamine—Ephedrine—BCHE—malignant glioma	0.00053	0.0584	CrCbGaD
Dextroamphetamine—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000528	0.00899	CcSEcCtD
Dextroamphetamine—Fatigue—Temozolomide—malignant glioma	0.000528	0.00898	CcSEcCtD
Dextroamphetamine—Constipation—Temozolomide—malignant glioma	0.000523	0.0089	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Carmustine—malignant glioma	0.000518	0.00881	CcSEcCtD
Dextroamphetamine—Body temperature increased—Carmustine—malignant glioma	0.000501	0.00852	CcSEcCtD
Dextroamphetamine—Abdominal pain—Carmustine—malignant glioma	0.000501	0.00852	CcSEcCtD
Dextroamphetamine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000501	0.00851	CcSEcCtD
Dextroamphetamine—Benzyl alcohol—CYP2B6—malignant glioma	0.0005	0.0551	CrCbGaD
Dextroamphetamine—Phenylpropanolamine—SLC6A3—malignant glioma	0.000496	0.0547	CrCbGaD
Dextroamphetamine—Urticaria—Temozolomide—malignant glioma	0.000486	0.00827	CcSEcCtD
Dextroamphetamine—Body temperature increased—Temozolomide—malignant glioma	0.000484	0.00823	CcSEcCtD
Dextroamphetamine—Abdominal pain—Temozolomide—malignant glioma	0.000484	0.00823	CcSEcCtD
Dextroamphetamine—Selegiline—CYP2B6—malignant glioma	0.00048	0.0529	CrCbGaD
Dextroamphetamine—Hypersensitivity—Carmustine—malignant glioma	0.000467	0.00794	CcSEcCtD
Dextroamphetamine—Asthenia—Carmustine—malignant glioma	0.000454	0.00773	CcSEcCtD
Dextroamphetamine—Hypersensitivity—Temozolomide—malignant glioma	0.000451	0.00767	CcSEcCtD
Dextroamphetamine—Phentermine—SLC6A3—malignant glioma	0.000442	0.0487	CrCbGaD
Dextroamphetamine—Asthenia—Temozolomide—malignant glioma	0.000439	0.00747	CcSEcCtD
Dextroamphetamine—Diarrhoea—Carmustine—malignant glioma	0.000433	0.00737	CcSEcCtD
Dextroamphetamine—CYP2D6—central nervous system—malignant glioma	0.000424	0.00765	CbGeAlD
Dextroamphetamine—Pseudoephedrine—SLC6A3—malignant glioma	0.000419	0.0462	CrCbGaD
Dextroamphetamine—Dizziness—Carmustine—malignant glioma	0.000419	0.00712	CcSEcCtD
Dextroamphetamine—Diarrhoea—Temozolomide—malignant glioma	0.000419	0.00712	CcSEcCtD
Dextroamphetamine—CYP2D6—cerebellum—malignant glioma	0.000414	0.00748	CbGeAlD
Dextroamphetamine—Dizziness—Temozolomide—malignant glioma	0.000405	0.00688	CcSEcCtD
Dextroamphetamine—Vomiting—Carmustine—malignant glioma	0.000403	0.00685	CcSEcCtD
Dextroamphetamine—Rash—Carmustine—malignant glioma	0.000399	0.00679	CcSEcCtD
Dextroamphetamine—Dermatitis—Carmustine—malignant glioma	0.000399	0.00679	CcSEcCtD
Dextroamphetamine—Headache—Carmustine—malignant glioma	0.000397	0.00675	CcSEcCtD
Dextroamphetamine—Pseudoephedrine—TNF—malignant glioma	0.000389	0.0429	CrCbGaD
Dextroamphetamine—Vomiting—Temozolomide—malignant glioma	0.000389	0.00662	CcSEcCtD
Dextroamphetamine—Rash—Temozolomide—malignant glioma	0.000386	0.00656	CcSEcCtD
Dextroamphetamine—Dermatitis—Temozolomide—malignant glioma	0.000386	0.00656	CcSEcCtD
Dextroamphetamine—Headache—Temozolomide—malignant glioma	0.000383	0.00652	CcSEcCtD
Dextroamphetamine—Nateglinide—PPARG—malignant glioma	0.000382	0.0421	CrCbGaD
Dextroamphetamine—Nausea—Carmustine—malignant glioma	0.000376	0.0064	CcSEcCtD
Dextroamphetamine—Benzphetamine—CYP2B6—malignant glioma	0.000367	0.0404	CrCbGaD
Dextroamphetamine—Nausea—Temozolomide—malignant glioma	0.000364	0.00618	CcSEcCtD
Dextroamphetamine—Amphetamine—SLC6A3—malignant glioma	0.00034	0.0375	CrCbGaD
Dextroamphetamine—CYP2D6—brain—malignant glioma	0.000336	0.00607	CbGeAlD
Dextroamphetamine—Methamphetamine—SLC6A3—malignant glioma	0.000315	0.0347	CrCbGaD
Dextroamphetamine—Benzphetamine—SLC6A3—malignant glioma	0.000312	0.0344	CrCbGaD
Dextroamphetamine—Nateglinide—PTGS1—malignant glioma	0.000282	0.0311	CrCbGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—F2—malignant glioma	3.64e-05	0.000691	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—PIK3CA—malignant glioma	3.64e-05	0.00069	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—KRAS—malignant glioma	3.59e-05	0.000682	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MDK—malignant glioma	3.54e-05	0.000671	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—FGF2—malignant glioma	3.51e-05	0.000667	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—BDKRB2—malignant glioma	3.5e-05	0.000664	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CXCR3—malignant glioma	3.47e-05	0.000659	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CXCR3—malignant glioma	3.4e-05	0.000645	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—COX8A—malignant glioma	3.38e-05	0.000641	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—DTX1—malignant glioma	3.38e-05	0.00064	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	3.37e-05	0.000639	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	3.33e-05	0.000631	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—PIK3CA—malignant glioma	3.3e-05	0.000626	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MDM2—malignant glioma	3.29e-05	0.000624	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—RAF1—malignant glioma	3.28e-05	0.000622	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—ERBB2—malignant glioma	3.24e-05	0.000615	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—F2—malignant glioma	3.23e-05	0.000614	CbGpPWpGaD
Dextroamphetamine—ADRA1B—G alpha (q) signalling events—PIK3CA—malignant glioma	3.23e-05	0.000612	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PIK3CB—malignant glioma	3.2e-05	0.000607	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—KNG1—malignant glioma	3.18e-05	0.000604	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—BDKRB2—malignant glioma	3.18e-05	0.000603	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	3.14e-05	0.000596	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—BDKRB2—malignant glioma	3.11e-05	0.00059	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CXCR3—malignant glioma	3.09e-05	0.000585	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CXCL8—malignant glioma	3.07e-05	0.000583	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SUFU—malignant glioma	3.02e-05	0.000573	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	2.99e-05	0.000568	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HEY2—malignant glioma	2.98e-05	0.000566	CbGpPWpGaD
Dextroamphetamine—TAAR1—GPCR downstream signaling—AKT1—malignant glioma	2.97e-05	0.000563	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	2.95e-05	0.00056	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—CASP3—malignant glioma	2.94e-05	0.000558	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—IL2—malignant glioma	2.94e-05	0.000557	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—GFAP—malignant glioma	2.91e-05	0.000553	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—KNG1—malignant glioma	2.89e-05	0.000548	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	2.89e-05	0.000548	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—ASMT—malignant glioma	2.87e-05	0.000545	CbGpPWpGaD
Dextroamphetamine—ADRA1A—G alpha (q) signalling events—PIK3CA—malignant glioma	2.87e-05	0.000544	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—KNG1—malignant glioma	2.83e-05	0.000536	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—BDKRB2—malignant glioma	2.82e-05	0.000535	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SPHK1—malignant glioma	2.82e-05	0.000535	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	2.79e-05	0.000529	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MMP9—malignant glioma	2.78e-05	0.000528	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PTEN—malignant glioma	2.76e-05	0.000525	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CCR4—malignant glioma	2.76e-05	0.000524	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HEY1—malignant glioma	2.76e-05	0.000524	CbGpPWpGaD
Dextroamphetamine—SLC6A2—Transmembrane transport of small molecules—RAF1—malignant glioma	2.74e-05	0.00052	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—BCAN—malignant glioma	2.7e-05	0.000513	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling by GPCR—AKT1—malignant glioma	2.7e-05	0.000512	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HIST1H3B—malignant glioma	2.68e-05	0.000509	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SUFU—malignant glioma	2.68e-05	0.000509	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HEY2—malignant glioma	2.65e-05	0.000503	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—GFAP—malignant glioma	2.59e-05	0.000491	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—KNG1—malignant glioma	2.57e-05	0.000487	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR ligand binding—CXCL8—malignant glioma	2.57e-05	0.000487	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	2.56e-05	0.000486	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—MMP3—malignant glioma	2.56e-05	0.000486	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SPHK1—malignant glioma	2.5e-05	0.000475	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—VEGFA—malignant glioma	2.5e-05	0.000474	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—STAT3—malignant glioma	2.47e-05	0.000469	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HEY1—malignant glioma	2.45e-05	0.000465	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CCR4—malignant glioma	2.45e-05	0.000465	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—JAG2—malignant glioma	2.45e-05	0.000465	CbGpPWpGaD
Dextroamphetamine—SLC6A3—Transmembrane transport of small molecules—RAF1—malignant glioma	2.43e-05	0.000461	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HIST1H3B—malignant glioma	2.38e-05	0.000452	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—MYC—malignant glioma	2.3e-05	0.000436	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR ligand binding—CXCL8—malignant glioma	2.28e-05	0.000432	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—MMP3—malignant glioma	2.27e-05	0.000432	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—EGFR—malignant glioma	2.25e-05	0.000426	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—IDH2—malignant glioma	2.18e-05	0.000413	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—JAG2—malignant glioma	2.18e-05	0.000413	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—KRAS—malignant glioma	2.12e-05	0.000403	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—H3F3A—malignant glioma	2.07e-05	0.000393	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—F2—malignant glioma	2.06e-05	0.00039	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCR3—malignant glioma	2.05e-05	0.000389	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP2B6—malignant glioma	2.05e-05	0.000389	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—YWHAE—malignant glioma	2e-05	0.000379	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NTRK2—malignant glioma	2e-05	0.000379	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FLT1—malignant glioma	1.99e-05	0.000377	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—DUSP6—malignant glioma	1.98e-05	0.000375	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CG—malignant glioma	1.97e-05	0.000374	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—JAG1—malignant glioma	1.95e-05	0.000371	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—PIK3CA—malignant glioma	1.95e-05	0.00037	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NOTCH3—malignant glioma	1.95e-05	0.000369	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FBXW7—malignant glioma	1.91e-05	0.000363	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—TP53—malignant glioma	1.89e-05	0.000358	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—BDKRB2—malignant glioma	1.88e-05	0.000356	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—IDH1—malignant glioma	1.87e-05	0.000355	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—F2—malignant glioma	1.87e-05	0.000354	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—H3F3A—malignant glioma	1.84e-05	0.000349	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—F2—malignant glioma	1.83e-05	0.000347	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCR3—malignant glioma	1.82e-05	0.000346	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SPHK1—malignant glioma	1.81e-05	0.000344	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—AKT2—malignant glioma	1.8e-05	0.000342	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CG—malignant glioma	1.79e-05	0.000339	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.78e-05	0.000337	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—YWHAE—malignant glioma	1.77e-05	0.000336	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NTRK2—malignant glioma	1.77e-05	0.000336	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FLT1—malignant glioma	1.77e-05	0.000335	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—DUSP6—malignant glioma	1.76e-05	0.000333	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PTPN11—malignant glioma	1.76e-05	0.000333	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CG—malignant glioma	1.75e-05	0.000332	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NOTCH2—malignant glioma	1.74e-05	0.000331	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—JAG1—malignant glioma	1.74e-05	0.000329	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CD—malignant glioma	1.73e-05	0.000328	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOTCH3—malignant glioma	1.73e-05	0.000328	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—KNG1—malignant glioma	1.71e-05	0.000324	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FBXW7—malignant glioma	1.7e-05	0.000323	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—BDKRB2—malignant glioma	1.67e-05	0.000316	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—F2—malignant glioma	1.66e-05	0.000315	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—AKT2—malignant glioma	1.64e-05	0.00031	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NTRK1—malignant glioma	1.63e-05	0.000309	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AKT2—malignant glioma	1.6e-05	0.000304	CbGpPWpGaD
Dextroamphetamine—TAAR1—Signaling Pathways—AKT1—malignant glioma	1.59e-05	0.000302	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CG—malignant glioma	1.59e-05	0.000301	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CD—malignant glioma	1.57e-05	0.000298	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PTPN11—malignant glioma	1.56e-05	0.000296	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOTCH2—malignant glioma	1.55e-05	0.000294	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CD—malignant glioma	1.54e-05	0.000292	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KNG1—malignant glioma	1.52e-05	0.000288	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MMP3—malignant glioma	1.51e-05	0.000287	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CB—malignant glioma	1.51e-05	0.000286	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CDKN2B—malignant glioma	1.5e-05	0.000285	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTK2—malignant glioma	1.46e-05	0.000276	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AKT2—malignant glioma	1.45e-05	0.000276	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—CXCL8—malignant glioma	1.45e-05	0.000275	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NTRK1—malignant glioma	1.45e-05	0.000274	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTT1—malignant glioma	1.44e-05	0.000272	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HES1—malignant glioma	1.43e-05	0.000271	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NCOR1—malignant glioma	1.42e-05	0.00027	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—RAF1—malignant glioma	1.4e-05	0.000266	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CD—malignant glioma	1.4e-05	0.000265	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—IL2—malignant glioma	1.39e-05	0.000263	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CB—malignant glioma	1.37e-05	0.00026	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PDGFRA—malignant glioma	1.36e-05	0.000258	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTGS1—malignant glioma	1.35e-05	0.000255	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MMP3—malignant glioma	1.34e-05	0.000255	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CB—malignant glioma	1.34e-05	0.000254	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CDKN2B—malignant glioma	1.33e-05	0.000253	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—SPP1—malignant glioma	1.32e-05	0.000251	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—CXCL8—malignant glioma	1.32e-05	0.00025	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTK2—malignant glioma	1.29e-05	0.000245	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—CXCL8—malignant glioma	1.29e-05	0.000244	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HES1—malignant glioma	1.27e-05	0.000241	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NCOR1—malignant glioma	1.26e-05	0.00024	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—IL2—malignant glioma	1.26e-05	0.000239	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TERT—malignant glioma	1.25e-05	0.000238	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—BCHE—malignant glioma	1.25e-05	0.000237	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—RAF1—malignant glioma	1.25e-05	0.000236	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.24e-05	0.000234	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—IL2—malignant glioma	1.23e-05	0.000233	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PDGFB—malignant glioma	1.22e-05	0.000232	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FGFR1—malignant glioma	1.22e-05	0.000231	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CB—malignant glioma	1.22e-05	0.000231	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PDGFRA—malignant glioma	1.21e-05	0.00023	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—HIF1A—malignant glioma	1.2e-05	0.000227	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—SPP1—malignant glioma	1.17e-05	0.000223	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—CXCL8—malignant glioma	1.17e-05	0.000222	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CAV1—malignant glioma	1.16e-05	0.00022	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—KDR—malignant glioma	1.15e-05	0.000218	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—IL2—malignant glioma	1.12e-05	0.000212	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TERT—malignant glioma	1.11e-05	0.000211	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—F2—malignant glioma	1.1e-05	0.000209	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FN1—malignant glioma	1.1e-05	0.000209	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—BAD—malignant glioma	1.09e-05	0.000207	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PDGFB—malignant glioma	1.09e-05	0.000206	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FGFR1—malignant glioma	1.08e-05	0.000205	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—NOTCH1—malignant glioma	1.08e-05	0.000205	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—HIF1A—malignant glioma	1.06e-05	0.000202	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CD80—malignant glioma	1.06e-05	0.000201	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CG—malignant glioma	1.06e-05	0.0002	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—APC—malignant glioma	1.06e-05	0.0002	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EGF—malignant glioma	1.04e-05	0.000198	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTPN11—malignant glioma	1.04e-05	0.000197	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CAV1—malignant glioma	1.03e-05	0.000195	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KDR—malignant glioma	1.02e-05	0.000193	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—GSTP1—malignant glioma	9.96e-06	0.000189	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—BRAF—malignant glioma	9.93e-06	0.000188	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—F2—malignant glioma	9.8e-06	0.000186	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FN1—malignant glioma	9.8e-06	0.000186	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CAT—malignant glioma	9.69e-06	0.000184	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—BAD—malignant glioma	9.69e-06	0.000184	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AKT2—malignant glioma	9.66e-06	0.000183	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—EGFR—malignant glioma	9.62e-06	0.000183	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—NOTCH1—malignant glioma	9.59e-06	0.000182	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CD80—malignant glioma	9.4e-06	0.000178	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—APC—malignant glioma	9.38e-06	0.000178	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CG—malignant glioma	9.38e-06	0.000178	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CD—malignant glioma	9.28e-06	0.000176	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EGF—malignant glioma	9.27e-06	0.000176	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTPN11—malignant glioma	9.22e-06	0.000175	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—PIK3CA—malignant glioma	9.2e-06	0.000174	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—NCOR1—malignant glioma	9.15e-06	0.000174	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—KRAS—malignant glioma	9.09e-06	0.000172	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—FGF2—malignant glioma	8.89e-06	0.000169	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—BRAF—malignant glioma	8.82e-06	0.000167	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AKT2—malignant glioma	8.58e-06	0.000163	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—EGFR—malignant glioma	8.55e-06	0.000162	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—PIK3CA—malignant glioma	8.35e-06	0.000158	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MDM2—malignant glioma	8.32e-06	0.000158	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—RAF1—malignant glioma	8.29e-06	0.000157	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CD—malignant glioma	8.25e-06	0.000156	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—ERBB2—malignant glioma	8.2e-06	0.000156	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—PIK3CA—malignant glioma	8.17e-06	0.000155	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CB—malignant glioma	8.09e-06	0.000154	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—KRAS—malignant glioma	8.07e-06	0.000153	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—FGF2—malignant glioma	7.9e-06	0.00015	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CXCL8—malignant glioma	7.78e-06	0.000148	CbGpPWpGaD
Dextroamphetamine—ADRA1B—GPCR downstream signaling—AKT1—malignant glioma	7.51e-06	0.000143	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—CAV1—malignant glioma	7.46e-06	0.000141	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—CASP3—malignant glioma	7.44e-06	0.000141	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—IL2—malignant glioma	7.43e-06	0.000141	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	7.42e-06	0.000141	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MDM2—malignant glioma	7.39e-06	0.00014	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—RAF1—malignant glioma	7.36e-06	0.00014	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	7.28e-06	0.000138	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	7.19e-06	0.000136	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MMP9—malignant glioma	7.03e-06	0.000133	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PTEN—malignant glioma	6.99e-06	0.000133	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	6.91e-06	0.000131	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	6.82e-06	0.000129	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CG—malignant glioma	6.79e-06	0.000129	CbGpPWpGaD
Dextroamphetamine—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	6.67e-06	0.000127	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—CASP3—malignant glioma	6.61e-06	0.000125	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—IL2—malignant glioma	6.6e-06	0.000125	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PPARG—malignant glioma	6.56e-06	0.000124	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	6.32e-06	0.00012	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—STAT3—malignant glioma	6.25e-06	0.000119	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MMP9—malignant glioma	6.25e-06	0.000119	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PTEN—malignant glioma	6.21e-06	0.000118	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	6.06e-06	0.000115	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CD—malignant glioma	5.97e-06	0.000113	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—MYC—malignant glioma	5.81e-06	0.00011	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—EGFR—malignant glioma	5.68e-06	0.000108	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	5.61e-06	0.000106	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—STAT3—malignant glioma	5.56e-06	0.000105	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—KRAS—malignant glioma	5.37e-06	0.000102	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CB—malignant glioma	5.21e-06	9.88e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—MYC—malignant glioma	5.16e-06	9.79e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTGS2—malignant glioma	5.16e-06	9.78e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—EGFR—malignant glioma	5.05e-06	9.58e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	4.93e-06	9.36e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—TP53—malignant glioma	4.77e-06	9.06e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—KRAS—malignant glioma	4.77e-06	9.05e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PTEN—malignant glioma	4.5e-06	8.53e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	4.38e-06	8.31e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—TP53—malignant glioma	4.24e-06	8.04e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1B—Signaling Pathways—AKT1—malignant glioma	4.03e-06	7.65e-05	CbGpPWpGaD
Dextroamphetamine—ADRA1A—Signaling Pathways—AKT1—malignant glioma	3.58e-06	6.79e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—PIK3CA—malignant glioma	3.17e-06	6.02e-05	CbGpPWpGaD
Dextroamphetamine—CYP2D6—Metabolism—AKT1—malignant glioma	2.59e-06	4.92e-05	CbGpPWpGaD
